# Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry)

> **NCT04790032** · — · COMPLETED · sponsor: **Federico II University** · enrollment: 150 (actual)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Cangrelor

## Key facts

- **NCT ID:** NCT04790032
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790032, "Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04790032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*